BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 11095619)

  • 1. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique roles for E2F1 in the mouse lens in the absence of functional pRB proteins.
    Hyde RK; Griep AE
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1509-16. PubMed ID: 11980867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
    Liu Y; Zacksenhaus E
    Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cell death by lens-specific overexpression of bcl-2 in transgenic mice.
    Fromm L; Overbeek PA
    Dev Genet; 1997; 20(3):276-87. PubMed ID: 9216067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
    Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q; Liang D; Yang T; Leone G; Overbeek PA
    Dev Neurosci; 2004; 26(5-6):435-45. PubMed ID: 15855772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ; Wang M; Breau RL; Henderson Y; El-Naggar AK; Steck KD; Sicard MW; Clayman GL
    Cancer Gene Ther; 1999; 6(2):163-71. PubMed ID: 10195883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chick delta1-crystallin enhancer influences mouse alphaA-crystallin promoter activity in transgenic mice.
    Reneker LW; Chen Q; Bloch A; Xie L; Schuster G; Overbeek PA
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4083-90. PubMed ID: 15505059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
    Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
    Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras modulates the cell cycle via both positive and negative regulatory pathways.
    Fan J; Bertino JR
    Oncogene; 1997 May; 14(21):2595-607. PubMed ID: 9191059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F-1-induced p53-independent apoptosis in transgenic mice.
    Holmberg C; Helin K; Sehested M; Karlström O
    Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
    Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
    Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.